<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for MAPP</title>
    <link />
    <description>Headlines for MAP Pharmaceuticals</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>Allergan Reaches 52-Week High - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/94074/allergan-reaches-52-week-high.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 05 Mar 2013 17:38:01 GMT</pubDate>
    </item>
    <item>
      <title>Allergan - MAP Acquisition Update - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/93948/allergan-map-acquisition-update.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Mon, 04 Mar 2013 16:30:01 GMT</pubDate>
    </item>
    <item>
      <title>Will Johnson &amp; Johnson Continue To Head Higher?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1244551-will-johnson-johnson-continue-to-head-higher.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 04 Mar 2013 13:20:16 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Wedbush Downgrades MAP Pharmaceuticals to Neutral, Reiterates $25 PT on Likely Acquisition</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3382287/update-wedbush-downgrades-map-pharmaceuticals-to-neutral.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Fri, 01 Mar 2013 14:08:40 GMT</pubDate>
    </item>
    <item>
      <title>Allergan, Inc. Announces Expiration of Tender Offer for All Outstanding Shares of MAP Pharmaceutical</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/01/allergan-inc-announces-expiration-of-tender-offer-/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Fri, 01 Mar 2013 09:21:24 GMT</pubDate>
    </item>
    <item>
      <title>Upcoming FDA Approval Decision Dates For Q2 2013</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1188371-upcoming-fda-approval-decision-dates-for-q2-2013.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 15 Feb 2013 13:43:46 GMT</pubDate>
    </item>
    <item>
      <title>Allergan's Healthy Prospects</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11836381/1/allergans-healthy-prospects.html.aspx?puc=aol&amp;cm_ven=aol&amp;source=itxwebtxt0000015</link>
      <author>TheStreet</author>
      <pubDate>Fri, 08 Feb 2013 06:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Allergan, Inc. and MAP Pharmaceuticals, Inc. Announce the Federal Trade Commission Has Granted Early</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/07/allergan-inc-and-map-pharmaceuticals-inc-announce-/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 07 Feb 2013 09:32:50 GMT</pubDate>
    </item>
    <item>
      <title>January Top 10: MAP Pharmaceuticals</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/02/05/january-top-ten-map-pharmaceuticals/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 05 Feb 2013 16:51:00 GMT</pubDate>
    </item>
    <item>
      <title>AGN Earnings Miss but Guidance Tops  - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/92041/agn-earnings-miss-but-guidance-tops.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 05 Feb 2013 16:28:01 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Strong Botox Sales Help Lift Allergan's Profits 16%</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130205-000424&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Tue, 05 Feb 2013 14:06:59 GMT</pubDate>
    </item>
    <item>
      <title>Allergan 4th-Quarter Profit Rose 16% Amid Growing Revenue, Fewer Charges</title>
      <link>http://www.fool.com/news/xt/smartmoney/www.smartmoney.com/news/on/.aspx?story=on-20130205-000247&amp;cid=1244&amp;source=itxwebtxt0000015</link>
      <author>Smart Money</author>
      <pubDate>Tue, 05 Feb 2013 09:44:59 GMT</pubDate>
    </item>
    <item>
      <title>MAP's Levadex Ready For FDA Approval</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1152371-map-s-levadex-ready-for-fda-approval.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 03 Feb 2013 03:55:26 GMT</pubDate>
    </item>
    <item>
      <title>Why I Sold Allergan</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1151721-why-i-sold-allergan.aspx?source=itxwebtxt0000015</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 01 Feb 2013 19:50:59 GMT</pubDate>
    </item>
    <item>
      <title>Update on AGN's Acquisition of MAP - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/91842/update-on-agns-acquisition-of-map.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Fri, 01 Feb 2013 16:50:01 GMT</pubDate>
    </item>
    <item>
      <title>Allergan Commences Cash Tender Offer for All Outstanding Shares of MAP Pharmaceuticals</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/01/31/allergan-commences-cash-tender-offer-for-all-outst/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Thu, 31 Jan 2013 09:25:29 GMT</pubDate>
    </item>
    <item>
      <title>Favorable Ruling for Allergan - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/91540/favorable-ruling-for-allergan.aspx?source=itxwebtxt0000015</link>
      <author>Zacks</author>
      <pubDate>Tue, 29 Jan 2013 18:50:01 GMT</pubDate>
    </item>
    <item>
      <title>UPDATE: Deutsche Bank Downgrades MAP Pharmaceuticals to Hold Following Acquisition Bid</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/01/3278780/update-deutsche-bank-downgrades-map-pharmaceuticals-to-h.aspx?source=itxwebtxt0000015</link>
      <author>Benzinga</author>
      <pubDate>Mon, 28 Jan 2013 08:56:44 GMT</pubDate>
    </item>
    <item>
      <title>Law Office of Brodsky &amp; Smith, LLC Announces Investigation of MAP Pharmaceuticals, Inc.</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/01/26/law-office-of-brodsky-smith-llc-announces-investig/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 26 Jan 2013 12:12:35 GMT</pubDate>
    </item>
    <item>
      <title>This Week in Biotech: Part 2</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/01/26/this-week-in-biotech-part-2-3/.aspx?source=itxwebtxt0000015</link>
      <author>DailyFinance</author>
      <pubDate>Sat, 26 Jan 2013 12:10:00 GMT</pubDate>
    </item>
  </channel>
</rss>
